Environmental Monitoring ; methods ; Environmental Pollutants ; analysis ; Microchip Analytical Procedures

The enzymological characterizations of site-mutagenized rat recombinant DNA polymerase?, RQ182 and RQ183 were studied The phosphocellulose column chromatographies showed that the mutant and the wild DNA polymerases were all eluted by about 0.5 mol/ L KCI, but the denatured DNA-cellulose chromatographies showed that although the wild enzyme was eluted by 0.35 mol/L KCI, RQ182 and RQ183 were eluted by 0.55 and 0.45 mol/L KCI, respectively, indicating that the binding abilities to DNA of the mutant enzymes were increased. Km values for the substrate (dTTP)of the wild enzyme, RQ182 and RQ183 were determined as 38.5, 34.5 and 111.1 ?mol/L, respectively,and the Km values for the primer (oligo(dT)) were 1.28, 1.96 and 6.58 ?g/ml, respectively. The results showed that the affinities of RQ183 to the substrate and the primer were decreased dramatically. It is suggested that Arg182 and Arg183 were involved in the active site function of DNA polymerase ?, in binding to DNA template, in recognizing of primer, and in binding to and catalyzing of substrates of the enzyme.

The prevalence of asthma in pregnant women appears to be increasing.Pregnant women with uncontrolled asthma may have an increased risk of adverse perinatal outcomes.Optimal management of asthma during pregnancy includes avoiding or controlling asthma triggers,individualized pharmacologic therapy,objective monitoring of lung function,and patient education.Inhaled corticosteroids are the preferred treatment for the management of all levels of persistent asthma during pregnancy.It is safer for pregnant women with asthma to be treated with asthma medications than to have asthma symptoms and exacerbations.The goal of asthma management during pregnancy is to optimize maternal and fetal health.

When the patients with chronic renal failure need drug therapy,we must select the appropriate drugs and adjust the drug delivery methods and dosage according to the renal function of these patients,at the same time we have to consider the factors such as age,sex,weight,combined medication,damage of other organs and so on,the therapeutic drug concentration monitoring should be paid attention to.For patients with blood purification,if the drug mainly removed by the kidneys,adjustments of drug administration must be based on the molecular weight of drug,volume of distribution,protein binding rate,mode of dialysis and hemodialyzer.We must ensure the drug efficacy and reduce the adverse reactions of drugs at the same time in the patients of renal insufficiency.

Objective:To prepare amphotericin B(AmB)-polybutylcyanoacrylate(PBCA) nanoparticle and evaluate its characteristics,so as to screen for the optimal preparation technique.Methods: AmB was loaded to blank PBCA nanoparticles by incubation to prepare AmB-PBCA nanoparticles.The surface of the nanoparticles was modified with polysorbate 80.The AmB concentration of AmB-PBCA-NP solution was calculated with the standard curve of AmB at D_(405),and the stability of solution was assessed.The diameter distribution of the particles was determined with Coulter Laser granulometer.The colloid solution of AmB-PBCA-NP was centrifuged and the supernatant was harvested to determine the concentration of AmB.The encapsulation rate,drug loading rate,and in vitro drug release were measured.The optimized preparation recipe was screened using diameter,drug loading rate,and encapsulation rate of the particles as indices.Results: The prepared AmB-PBCA nanoparticle had a regular spherical or elliptic surface,with a mean diameter of(69.01?28.56) nm.The curve of standard AmB was linear within the range of 1.12-5.60 ?g/ml: D_(405)=0.163 4c+0.006 6(r=0.999 3).The average recovery of AmB-PBCA-NP was(99.93%,) showing the solution of AmB-PBCA-NP was stable within 12 h.The nanoparticles showed a sustained drug release in vitro within 24 h.The optimized recipe was: DextranT-70 stabilizer without sodium deoxycholate,with a mean encapsulation rate of 56.10% and a drug loading rate of 82%.Conclusion: The current method for preparing AmB-PBCA nanoparticles is simple and can meet the requirements of pharmaceutics.

Retinal angiomatous proliferation(RAP) is a special type of age-related macular degeneration (AMD) with a pathological process of neovascularization.Different with several types of neovascular AMD,the new blood vessel in RAP is believed to originate from the inner retinal circulation.Because of inadequate knowledge,there still exist some limited understanding for this disease,such as its clinical diagnosis,therapy effectiveness and its poor prognosis.The newest interpretation about RAP was based on the findings of indocyanine green angiography(ICGA) and the first generation of optical coherence tomography (OCT) imaging system.The stage,histogenesis,histopathology,nature process,fundus findings,differentiating diagnosis and treatrnent of RAP were reviewed.

In this paper,our study on cultivating the quality and capabilities of the med-ical students in obstetrics and gynecology practice shows that quality education is the key to training talented students with lofty ethics,professional skills and humanities knowledge.

In recent years,more and more experts and scholars study enhancer of zeste homolog 2 (EZH2) and the relationship of the overexpression of EZH2 gene with the occurrence,development,metastasis,and prognosis of tumor,to explore the early diagnosis of cancer,monitoring metastasis and judging the prognosis to provide the new ideas and the methods,to provide the reference for the basic and clinical research.

Deep vein thrombosis is one of venous thromboembolism clinical manifestations,but also a serious,potentially dangerous disease.Thrombosis can occur in various parts of the body veins,and deep venous thrombosis is the most common.Even though most patients with DVT have no clinical symptoms or with mild symptoms,but failure to timely appropriate treatment is easy to progress to post thrombotic syndrome,shares bruises,stock white swollen,which can occur in severe pulmonary embolism and cause death.Although clinically in a variety of measures to prevent DVT formation,including physical prevention and drug prevention,but the incidence of deep vein thrombosis remains high,9-36％ after total hip arthroplasty,and 52％ after total knee arthroplasty.DVT is a disease combined with genetic and non-genetic factors,60％ DVT patients have hereditary risk factors.Currently genetic factors on the formation of DVT study find that clotting factor Ⅺ gene polymorphisms is associated with DVT.Coagulation factor Ⅺ (F Ⅺ) is a serine protease synthesized by the liver and plays an important role in the coagulation cascade process such as maintain the amplification process and the intrinsic pathway.Research on correlation between single nucleotide polymorphisms (SNPs) of F Ⅺ locus rs2289252 and rs2036914 and deep vein thrombosis has become popular.This paper reviews the discovery of coagulation F Ⅺ single nucleotide polymorphism associated with DVT,the degree of association between coagulation F Ⅺ single nucleotide polymorphism and the formation of DVT,risk allele on the clotting F Ⅺ single nucleotide polymorphism,clinical trials of coagulation F Ⅺ and the formation of DVT,coagulation F Ⅺ single nucleotide polymorphisms interact with other genetic polymorphisms,etc.Although the single nucleotide polymorphism in DVT formation mechanism is still vague,we believe that further study of single nucleotide polymorphisms associated with DVT will provide new approaches to prevention and treatment of DVT.

Asthma is a chronic airway inflammatory disease,which is caused by both genetic and environmental factors.For one thing, asthma is associated with genetic factors;for another thing, many exogenous triggering factors,such as diatery intake, smoke exposure and air pollution can impact on the development of asthma.Recently,many studies have showed that epigenetic changes which are influenced by the both factors play an important role in the pathophysiology of asthma.This article reviews the update advances about the epigenetic regulation and epigenetic therapy in asthma.